Latest News and Press Releases

RALEIGH, Carolina del Norte, Sept. 16, 2020 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ:PRAH) ha anunciado hoy el nombramiento de Glen Stettin, doctor en medicina, como consejero del...

RALEIGH, Carolina do Norte, Sept. 16, 2020 (GLOBE NEWSWIRE) -- A PRA Health Sciences, Inc. (NASDAQ:PRAH) anunciou hoje a nomeação do Doutor Glen Stettin para o Conselho de Administração da Empresa,...

RALEIGH, N.C., Sept. 17, 2020 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ:PRAH) hari mengumumkan pelantikan Glen Stettin, M.D. kepada Lembaga Pengarah Syarikat, berkuat kuasa pada 14...

미국 노스캐롤라이나주 롤리, Sept. 17, 2020 (GLOBE NEWSWIRE) -- PRA 헬스사이언스(PRA Health Sciences, Inc. (NASDAQ:PRAH))는 글렌 스테틴(Glen Stettin, 일반의)이 2020년 9월 14일부로 이사회 임원으로 선임됐다고 발표했다. 콜린 섀넌(Colin Shannon) PRA...

ノースカロライナ州ローリー発, Sept. 17, 2020 (GLOBE NEWSWIRE) -- PRAヘルスサイエンス (PRA Health Sciences, Inc.) (NASDAQ:PRAH) は本日、2020年9月14日付でグレン･ステッティン医学博士 (Glen Stettin, M.D.) を同社取締役に任命したことを発表した。 ...

RALEIGH, N.C., Sept. 15, 2020 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ:PRAH) today announced the appointment of Glen Stettin, M.D. to the Board of Directors of the Company, effective...

Net new business of $701.6 million; Net book-to-bill of 1.35 excluding reimbursement revenueNet new business of $1,083.3 million; Net book-to-bill of 1.62 including reimbursement revenue$729.9 million...

RALEIGH, N.C., July 02, 2020 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ: PRAH) will release its second quarter 2020 results after the market closes on Thursday, August 6, 2020. The...

RALEIGH, Caroline du Nord, 18 juin 2020 (GLOBE NEWSWIRE) -- Entre 2007 et 2017, 78 nouveaux agents anticancéreux chez les adultes ont été approuvés par la Food and Drug Administration des...

北卡羅萊納州拉里市, June 19, 2020 (GLOBE NEWSWIRE) -- 在 2007 年至 2017 年之間，美國食品及藥物監督管理局 (FDA) 共批准了 78 種新的成年癌症藥物，1 但這些藥物均未進行旨在確定其對兒科癌症藥效的研究。 這種情況將在《RACE 法案》（即兒童研究平等法案）於 8 月 18 日生效時發生變化。《RACE 法案》於 2017...